These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21250406)

  • 1. [The influence of the relationship between physicians and pharmaceutical companies on the patient from the point of view of policy-makers in Israel].
    Nissanholtz-Gannot R; Shani S; Shvarts S
    Harefuah; 2010 Nov; 149(11):688-92, 750. PubMed ID: 21250406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care physicians in Israel: self-perception of their role in the healthcare system and policy makers' and patients' perception of them as gatekeepers.
    Tabenkin H; Gross R; Greenberg SB; Steinmetz D; Elhayany A
    Isr Med Assoc J; 2001 Dec; 3(12):893-7. PubMed ID: 11794909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of pharmaceutical companies.
    Messmer JJ
    J Fam Pract; 2000 Dec; 49(12):1154; author reply 1155. PubMed ID: 11132069
    [No Abstract]   [Full Text] [Related]  

  • 5. The physician's relationship with the pharmaceutical industry: caveat emptor...buyer beware!
    Albersheim SG; Golan A
    Isr Med Assoc J; 2011 Jul; 13(7):389-93. PubMed ID: 21838178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of pharmaceutical companies.
    Parnes B
    J Fam Pract; 2000 Dec; 49(12):1154-5. PubMed ID: 11132068
    [No Abstract]   [Full Text] [Related]  

  • 7. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.
    Greenland P
    Arch Intern Med; 2009 May; 169(9):829-31. PubMed ID: 19433693
    [No Abstract]   [Full Text] [Related]  

  • 8. Doctors and drug companies--scrutinizing influential relationships.
    Campbell EG
    N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
    [No Abstract]   [Full Text] [Related]  

  • 9. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
    Castresana L; Mejia R; Aznar M
    Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.
    CMAJ; 1994 Jan; 150(2):256A-256F. PubMed ID: 8287348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The physician and the pharmaceutical industry].
    Moncada B; Acevedo-Oliva B
    Gac Med Mex; 1990; 126(4):343-7. PubMed ID: 2093573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 19. Physicians' interactions with pharmaceutical companies.
    Procopio L
    Pediatrics; 1992 Aug; 90(2 Pt 1):281-2. PubMed ID: 1641301
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of the pharmaceutical industry on treatment guidelines].
    Smulders YM; Thijs A
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.